SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 42.27 |
| Enterprise Value ($M) | 83.82 |
| Book Value ($M) | 8.84 |
| Book Value / Share | 0.39 |
| Price / Book | 4.78 |
| NCAV ($M) | -103.28 |
| NCAV / Share | -4.59 |
| Price / NCAV | -0.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.28 |
| Current Ratio | 0.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 20.56 |
| Assets | 132.68 |
| Liabilities | 123.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 54.22 |
| Operating Income | -38.55 |
| Net Income | -57.89 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.40 |
| Cash from Investing | 0.51 |
| Cash from Financing | 6.70 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Dragasac Ltd | 36.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 199,527 | 639,247 | 31.21 | |
| 18,741 | 49,907 | 37.55 | |
| 2,685 | 21,875 | 12.27 | |
| 2,552 | 13,740 | 18.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CASI – CASI Pharmaceuticals, Inc. | CDIO – Cardio Diagnostics Holdings, Inc. |
| CDTX – Cidara Therapeutics, Inc. | CELZ – Creative Medical Technology Holdings, Inc. |
| CGEN – Compugen Ltd. |
Financial data and stock pages provided by
Fintel.io